Abstract
We evaluated the COBAS Ampliscreen hepatitis B virus (HBV) test using standards, seroconversion panels, consecutive donations, and samples from patients with abnormal alanine aminotransferase and chronic hepatitis C. Specificity was 100% and sensitivity was 20 IU/ml. In seroconversion panels, HBV DNA was detected up to 4 to 18 days before HBsAg, suggesting that this assay is useful in shortening the infectious window phase.
Publication types
-
Evaluation Study
-
Multicenter Study
MeSH terms
-
Blood Donors*
-
DNA, Viral / blood*
-
Hepatitis B / diagnosis*
-
Hepatitis B / virology
-
Hepatitis B Surface Antigens / blood
-
Hepatitis B virus / isolation & purification*
-
Humans
-
Nucleic Acid Amplification Techniques / methods*
-
Nucleic Acid Amplification Techniques / standards
-
Polymerase Chain Reaction / instrumentation
-
Polymerase Chain Reaction / methods
-
Sensitivity and Specificity
Substances
-
DNA, Viral
-
Hepatitis B Surface Antigens